Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) — Capital Reinvestment Ratio
Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a Capital Reinvestment Ratio of 1.27x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥9.12 Million) in capital expenditures (CN¥11.62 Million). See 300942 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shenzhen Bioeasy Biotechnology Co. Ltd. Capital Reinvestment Ratio (2016–2025)
This chart tracks Shenzhen Bioeasy Biotechnology Co. Ltd.'s Capital Reinvestment Ratio across 9 annual periods. Check 300942 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)
Year-by-year Capital Reinvestment Ratio for Shenzhen Bioeasy Biotechnology Co. Ltd. from 2016 to 2025. For live market cap and broader valuation context, see 300942 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.69x | CN¥66.87 Million | CN¥45.90 Million | ▼ -86.5% |
| 2024 | 5.08x | CN¥34.26 Million | CN¥174.10 Million | ▲ +338.4% |
| 2022 | 1.16x | CN¥152.55 Million | CN¥176.85 Million | ▲ +272.4% |
| 2021 | 0.31x | CN¥255.42 Million | CN¥79.51 Million | ▼ -76.0% |
| 2020 | 1.30x | CN¥63.79 Million | CN¥82.84 Million | ▲ +232.1% |
| 2019 | 0.39x | CN¥67.24 Million | CN¥26.29 Million | ▲ +115.1% |
| 2018 | 0.18x | CN¥57.93 Million | CN¥10.53 Million | ▼ -60.3% |
| 2017 | 0.46x | CN¥23.60 Million | CN¥10.82 Million | ▲ +84.4% |
| 2016 | 0.25x | CN¥36.31 Million | CN¥9.03 Million | — |